Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Aug
31
2013
United Kingdom Government Confirms Change to Sustainability Criteria for Biomass McDermott Will & Emery
Oct
4
2013
Solar Energy Industries Association Proposes Compromise Plan for U.S. - China Solar Conflict McDermott Will & Emery
Oct
10
2013
Massachusetts Department of Energy Resources (DOER) Finalizes Rules for Solar Carve-Out Program McDermott Will & Emery
Oct
12
2021
PhRMA Code Revisions To Go Into Effect January 2022 McDermott Will & Emery
Oct
26
2018
McDermott's Plus Check-up: October 26, 2018 McDermott Will & Emery
Jan
9
2014
Energy Regulators FERC (Federal Energy Regulatory Commission), CFTC (Commodity Futures Trading Commission) Finally Reach Proactive Understanding on Jurisdiction and Information Sharing McDermott Will & Emery
Jan
11
2022
Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure McDermott Will & Emery
Feb
13
2019
DOJ Expands New Enforcement Tactic – Obtains TRO to Prevent Pharmacy From Dispensing Opioids McDermott Will & Emery
Feb
22
2022
TTB Publishes Phase 2 of Labeling and Advertising Modernization Rule McDermott Will & Emery
Oct
22
2014
Mushroom Growers Denied Capper-Volstead Antitrust Immunity McDermott Will & Emery
Mar
3
2015
Third Circuit Affirms MillerCoors Victory in Wholesaler Contract Dispute McDermott Will & Emery
Mar
19
2015
FDA Issues Revised Draft Guidance on Disclosures of Risk Information in Consumer-Friendly Print Advertisements and Promotional Labeling McDermott Will & Emery
Apr
8
2015
The Newborn Screening Saves Lives Reauthorization Act: Implications for Human Subjects Research McDermott Will & Emery
Apr
22
2015
Buying and Selling a Craft Brewery in the United States McDermott Will & Emery
Jul
1
2015
FDA Announces Delay in Enforcing DSCSA Requirements for Dispensers McDermott Will & Emery
Dec
24
2022
Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition McDermott Will & Emery
Sep
29
2015
Chicken Sandwich Recipe, Name Not Eligible for Copyright Says First Circuit McDermott Will & Emery
Jan
6
2023
TTB Industry Circular 3: Calculating Tax Rates and Tax Credits on Imported Distilled Spirits McDermott Will & Emery
Dec
2
2019
Key Considerations for Investments in Entities Developing Innovative FDA-Regulated Products McDermott Will & Emery
Jan
16
2020
US Office of Management and Budget Issues a Memorandum Calling for Agency Plans From Federal Government Agencies McDermott Will & Emery
Mar
16
2020
TTB Relaxes Consignment Sale Restrictions in Wake of Coronavirus Cancellations McDermott Will & Emery
Jul
6
2023
Key Takeaways | Women’s Health/Women+: Tapping into an Underserved Market McDermott Will & Emery
Jun
14
2016
FDA to Hold Public Workshops Addressing Menu Labeling Final Rule McDermott Will & Emery
Apr
1
2020
Detailed Summary of Federal Requirements for Production of Hand Sanitizing Products McDermott Will & Emery
May
18
2020
Fast Track For COVID-19 Drug And Vaccine Approval In The United States And Europe McDermott Will & Emery
Sep
20
2016
FDA Extends Deadline for Removal of NDC and NHRIC Numbers from Device Labeling and Packaging McDermott Will & Emery
Aug
20
2020
What the Latest Executive Order Means for Federal Contractors and FDA McDermott Will & Emery
Feb
2
2017
FDA Clarifies “Intended Use” for Drugs, Devices, and Tobacco Products McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins